「lifeforpeoplearound the world」の検索結果
28件：16～20件目を表示
-
g approval in Japan as of December 22, 2025. Avarept® Ophthalmic suspension 0.3% represents a novel therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1)*1 anta...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
Management Policy | About Senju | SENJU Pharmaceutical
valuable for society, we are committed to pursuing happiness for all people associated with Senju rather than just becoming a “big company” that pursues only greater growth and increased sales. Action...
https://www.senju.co.jp/english/about/philosophy.html -
treatment for Dry Eye Disease (DED), has been launched in Japan today. Avarept® represents a novel therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1) *1 ant...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406_0.pdf -
全球业务开展 | 海外活动 | 千寿制药株式会社
海外基地 北京代表处中国，北京 1606B，16th Floor, West Tower, World Financial Centre No.1, East 3rd Ring Middle Road, Chaoyang District, Beijing, P.R.C. Postal Code：100020 Tel：+86-10-6533-0200 Fax：+86-10-6536-1329 千寿...
http://www.senju.co.jp/chinese/global/ -
グローバル展開 | 会社情報 | 千寿製薬株式会社
薬有限公司を設立しマーケティング活動の体制の充実を図っており、国際化への基礎づくりを着々と進めています。 海外拠点 北京事務所中国（北京） 1606B，16th Floor, West Tower, World Financial Centre No.1, East 3rd Ring Middle Road, Chaoyang District, Beijing, P.R.C. Postal Co...
https://www.senju.co.jp/about/global/